Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine (Q39172114)

9 September 2017

title

Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine (English)

1 reference

eradication of infectious diseases

9 September 2017

main subject

1 reference

O Igoucheva

1 reference

9 September 2017

M Grazzini

1 reference

9 September 2017

A Pidich

1 reference

9 September 2017

D M Kemp

1 reference

9 September 2017

M Larijani

1 reference

9 September 2017

M Farber

1 reference

9 September 2017

J Lorton

1 reference

9 September 2017

U Rodeck

1 reference

9 September 2017

V Alexeev

1 reference

9 September 2017

publication date

4 April 2013

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

page(s)

939-948

1 reference

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Adoptive cell therapy for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Ipilimumab: first global approval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Ipilimumab: controversies in its development, utility and autoimmune adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Peptide vaccine trials for melanoma: preclinical background and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Dendritic cell-based vaccines for pancreatic cancer and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Fusion of antigen to chemokine CCL20 or CXCL13 strategy to enhance DNA vaccine potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Conditioning vaccination site with irradiated MIP-3alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

CC chemokine receptor 6 expression by B lymphocytes is essential for the development of isolated lymphoid follicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

The good and the bad of chemokines/chemokine receptors in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

A crucial role for dendritic cell (DC) IL-10 in inhibiting successful DC-based immunotherapy: superior antitumor immunity against hepatocellular carcinoma evoked by DC devoid of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

CDKN2A and MC1R analysis in amelanotic and pigmented melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+ T cells in the lesional skin of a patient with melanoma-related depigmentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Functional analysis of the slaty gene product (TRP2) as dopachrome tautomerase and the effect of a point mutation on its catalytic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

Improved melanoma survival at last! Ipilimumab and a paradigm shift for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

7 January 2021

Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

7 January 2021

Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

7 January 2021

Systematic microanatomical analysis of CXCL13 and CCL21in situ production and progressive lymphoid organization in rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

7 January 2021

The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

7 January 2021

Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

7 January 2021

Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.17

7 January 2021

Identifiers

DOI

10.1038/GT.2013.17

1 reference

Dimensions Publication ID

9 September 2017

1042041002

0 references

1 reference